Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Endocarditis: Understanding Causes, Symptoms, and Treatment Options

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

Endocarditis is a potentially life-threatening infection of the heart's inner lining (endocardium), often affecting the heart's valves. It can result in severe health conditions such as heart failure and embolic events. Early diagnosis and treatment are crucial to prevent these severe outcomes.Β 

This article provides a comprehensive guide for understanding infective endocarditis, including its pathophysiology, risk factors, symptoms, diagnostic criteria, and management strategies, to enhance clinical awareness and improve patient care.

[signup]

Understanding Endocarditis

Endocarditis can cause growths on the heart's valves (vegetations) and produce toxins that damage the heart's tissue and valves. It is more common in men and older people, with 25% of cases occurring in those over 60.Β 

There are two main types of endocarditis:Β 

[17]

Pathophysiology

Infective endocarditis develops when bacteria or fungi enter the bloodstream, often through breaches in the skin or mucous membranes. These pathogens travel to the heart, attaching to valves or other damaged areas. The heart valves are particularly vulnerable because they lack blood supply, making it harder for the immune system to fight the infection.

Formation of Vegetations

Once the pathogens adhere to the heart valves, they multiply and trigger an immune response, leading to vegetation formation. These vegetations are clumps of microorganisms, platelets, fibrin, and cellular debris. They can cause valve dysfunction, leading to severe complications like heart failure, sepsis, arrhythmia, or systemic embolization (blood clot blocking a major artery).

Causes and Risk Factors

The most common cause of infective endocarditis is a bacterial infection. Streptococcus and Staphylococcus species are the primary culprits. Streptococcus viridans is often responsible for endocarditis following dental procedures, while Staphylococcus aureus is commonly associated with skin infections and intravenous drug use.

Fungal endocarditis, though less common, is more complicated to treat. Candida and Aspergillus species are the most common fungi implicated. These infections are more likely in immunocompromised individuals or those with prolonged antibiotic use.

Risk Factors

Risk factors for developing endocarditis include:

  • Pre-existing Heart Conditions: Conditions like congenital heart defects, damaged heart valves, and artificial (prosthetic) valves significantly increase the risk of endocarditis. These abnormalities provide surfaces for pathogens to adhere to and multiply.
  • Medical Procedures: Certain procedures, such as pacemaker insertion, dental work, surgeries, and cardiac catheterizations, can introduce pathogens into the bloodstream, increasing endocarditis risk.
  • Intravenous (IV) Drug Use: Recreational IV drug (e.g., heroin) use is a significant risk factor for endocarditis. Non-sterile injection practices introduce bacteria directly into the bloodstream, increasing the likelihood of heart infections.
  • Immunocompromised Status: Those with weakened immune systems, such as people with HIV/AIDS, diabetes, or undergoing chemotherapy, are more susceptible to infections, including endocarditis.

Symptoms of Endocarditis

Common symptoms of endocarditis include:Β 

  • Fever and Chills: Fever (> 100.4 F) and chills are early signs of endocarditis. These symptoms are the body's immune response to infection.
  • Heart Murmurs: New or changing heart murmurs can indicate valve involvement in endocarditis. Murmurs are caused by turbulent blood flow through damaged valves.
  • Fatigue and Weakness: Fatigue and general malaise are nonspecific symptoms often experienced by individuals with endocarditis due to the body's ongoing battle with infection.
  • Shortness of Breath: Endocarditis can lead to heart dysfunction, causing shortness of breath, particularly during physical activity or when lying down.
  • Petechiae: Small red or purple spots, known as petechiae, can appear on the skin or inside the mouth due to broken capillaries, often resulting from emboli (small blood clots) or vasculitis (inflammation of blood vessels)Β  associated with endocarditis.

Symptoms Specific to Complications

Untreated endocarditis can lead to significant morbidity.Β  Symptoms of complications arising from endocarditis include:

  • Embolic Events: Pieces of the vegetations can break off (emboli) and travel from the heart to other organs, causing symptoms based on the affected area. For instance, a stroke may occur if emboli reach the brain, while a pulmonary embolism affects the lungs, and infarctions can occur in other organs.
  • Heart Failure: Symptoms of heart failure, such as severe fatigue, shortness of breath, and swelling in the legs or abdomen, can develop if endocarditis significantly damages the heart valves.

Diagnosis of Endocarditis

A thorough history-taking and physical examination are vital in diagnosing endocarditis. A detailed medical and social history can reveal potential exposure to risk factors, and a physical exam can identify signs of infection and complications.Β Β 

Diagnostic Criteria and Evaluation

  • Duke Criteria: The Duke criteria are essential for diagnosing infective endocarditis, combining clinical, microbiological, and echocardiographic findings to establish a diagnosis.
  • Blood Cultures: Obtaining multiple blood cultures is crucial to identifying the causative organisms. This process involves drawing blood samples at different times to increase the likelihood of detecting the pathogens.
  • Echocardiography: Transthoracic (TTE) and transesophageal echocardiography (TEE) are used to visualize vegetations in the heart and assess valve damage. TEE is more sensitive and often used when TTE results are inconclusive.
  • Laboratory Tests: Additional tests can support the diagnosis by indicating inflammation and infection, including a complete blood count (CBC), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR).

Treatment and Management of Endocarditis

Medical management consists of aggressive antibiotic or antifungal treatments. Surgical intervention is often provided in conjunction with medical therapy if significant damage to the heart tissue or valves occurs. Hospitalization is usually required for monitoring and intensive treatment. Patients need close supervision to manage the infection and prevent complications.

Medical Management

  • Antibiotic Therapy: The cornerstone of endocarditis treatment is intravenous antibiotic therapy. The choice of antibiotics is based on the infective organism, and treatment typically lasts several weeks to ensure the infection is entirely eradicated.
  • Antifungal Therapy: Antifungal medications are required for fungal endocarditis. These infections are more challenging to treat and may necessitate longer therapy courses.

Surgical Interventions

  • Valve Repair or Replacement: Surgical intervention may be required to repair or replace damaged valves, mainly if the infection has caused significant valve dysfunction or if there are vegetations at risk of embolization.
  • Removal of Infected Tissue: Removal of infected tissue may be required to prevent the spread of the infection and stabilize the patient's condition.

Prognosis and Complications

The prognosis of endocarditis depends on various factors, including the causative organism, the patient's overall health, and the presence of complications. Early diagnosis and appropriate treatment improve outcomes.

Complications of endocarditis can include recurrent infections, heart failure, and stroke. These complications can significantly impact a patient's long-term health and quality of life.

Managing Complications

Early detection and treatment of complications are crucial for improving outcomes. Regular follow-up and monitoring are necessary to catch and address issues promptly.Β  Ongoing care, including patient education, is vital to prevent recurrence. Patients should be educated on recognizing warning signs and adhering to preventive measures.

Prevention and Patient Education

Essential prevention strategies include the following measures:

  • Prophylactic antibiotics may be recommended for high-risk patients undergoing certain medical or dental procedures to prevent endocarditis.
  • Maintaining good oral hygiene can prevent infections that could lead to endocarditis. Routine dental check-ups and proper oral care are crucial.
  • Education on the risks of IV drug use and strategies for harm reduction can help prevent endocarditis in this high-risk population.

Patient and Caregiver Education

Understanding Endocarditis and Treatment Adherence -Patients and caregivers should understand the condition and the importance of adhering to treatment plans to ensure successful outcomes.

Educating patients and caregivers on recognizing warning signs of recurrence or complications can lead to timely medical intervention and better management of endocarditis.

[signup]

Key Takeaways

  • Endocarditis is an infection of the heart's inner lining, typically involving the valves.
  • The infection usually starts when bacteria or fungi enter the bloodstream and attach to heart valves, forming vegetations of microorganisms, platelets, and cellular debris.
  • Bacterial infections, particularly those caused by Streptococcus and Staphylococcus species, are the most common causes. Risk factors include pre-existing heart conditions, medical procedures, IV drug use, and immunocompromised states.
  • Recognizing symptoms like fever, chills, heart murmurs, fatigue, shortness of breath, and complications such as embolic events and heart failure is essential.
  • The Duke criteria, blood cultures, echocardiography, and laboratory tests are critical for diagnosing endocarditis.
  • Management involves intravenous antibiotic or antifungal therapy and may require surgical interventions such as valve repair or replacement.
  • Early detection and treatment are vital for a better prognosis, with potential complications including recurrent infections, heart failure, and stroke.
  • Preventive strategies like antibiotic prophylaxis for high-risk patients, good oral hygiene, and avoiding IV drug use, along with patient education, are crucial for reducing the risk of endocarditis.
  • Future therapies for endocarditis may include the development of more targeted antibiotics and antifungal treatments, as well as advances in non-invasive imaging techniques for earlier and more accurate diagnosis. Ongoing research efforts are directed toward understanding the molecular mechanisms of endocarditis to improve prevention and create personalized treatment plans.

Endocarditis is a serious infection of the heart's inner lining (endocardium), often affecting the heart's valves. It can lead to significant health issues such as heart failure and embolic events. Early diagnosis and management are important to help reduce the risk of these outcomes.Β 

This article provides a comprehensive guide for understanding infective endocarditis, including its pathophysiology, risk factors, symptoms, diagnostic criteria, and management strategies, to enhance clinical awareness and support patient care.

[signup]

Understanding Endocarditis

Endocarditis can cause growths on the heart's valves (vegetations) and produce substances that may harm the heart's tissue and valves. It is more common in men and older people, with 25% of cases occurring in those over 60.Β 

There are two main types of endocarditis:Β 

[17]

Pathophysiology

Infective endocarditis develops when bacteria or fungi enter the bloodstream, often through breaches in the skin or mucous membranes. These pathogens travel to the heart, attaching to valves or other damaged areas. The heart valves are particularly vulnerable because they lack blood supply, making it harder for the immune system to manage the infection.

Formation of Vegetations

Once the pathogens adhere to the heart valves, they multiply and trigger an immune response, leading to vegetation formation. These vegetations are clumps of microorganisms, platelets, fibrin, and cellular debris. They can cause valve dysfunction, leading to severe complications like heart failure, sepsis, arrhythmia, or systemic embolization (blood clot blocking a major artery).

Causes and Risk Factors

The most common cause of infective endocarditis is a bacterial infection. Streptococcus and Staphylococcus species are the primary culprits. Streptococcus viridans is often responsible for endocarditis following dental procedures, while Staphylococcus aureus is commonly associated with skin infections and intravenous drug use.

Fungal endocarditis, though less common, is more complicated to manage. Candida and Aspergillus species are the most common fungi implicated. These infections are more likely in immunocompromised individuals or those with prolonged antibiotic use.

Risk Factors

Risk factors for developing endocarditis include:

  • Pre-existing Heart Conditions: Conditions like congenital heart defects, damaged heart valves, and artificial (prosthetic) valves significantly increase the risk of endocarditis. These abnormalities provide surfaces for pathogens to adhere to and multiply.
  • Medical Procedures: Certain procedures, such as pacemaker insertion, dental work, surgeries, and cardiac catheterizations, can introduce pathogens into the bloodstream, increasing endocarditis risk.
  • Intravenous (IV) Drug Use: Recreational IV drug (e.g., heroin) use is a significant risk factor for endocarditis. Non-sterile injection practices introduce bacteria directly into the bloodstream, increasing the likelihood of heart infections.
  • Immunocompromised Status: Those with weakened immune systems, such as people with HIV/AIDS, diabetes, or undergoing chemotherapy, are more susceptible to infections, including endocarditis.

Symptoms of Endocarditis

Common symptoms of endocarditis include:Β 

  • Fever and Chills: Fever (> 100.4 F) and chills are early signs of endocarditis. These symptoms are the body's immune response to infection.
  • Heart Murmurs: New or changing heart murmurs can indicate valve involvement in endocarditis. Murmurs are caused by turbulent blood flow through damaged valves.
  • Fatigue and Weakness: Fatigue and general malaise are nonspecific symptoms often experienced by individuals with endocarditis due to the body's ongoing battle with infection.
  • Shortness of Breath: Endocarditis can lead to heart dysfunction, causing shortness of breath, particularly during physical activity or when lying down.
  • Petechiae: Small red or purple spots, known as petechiae, can appear on the skin or inside the mouth due to broken capillaries, often resulting from emboli (small blood clots) or vasculitis (inflammation of blood vessels)Β  associated with endocarditis.

Symptoms Specific to Complications

Untreated endocarditis can lead to significant health challenges.Β  Symptoms of complications arising from endocarditis include:

  • Embolic Events: Pieces of the vegetations can break off (emboli) and travel from the heart to other organs, causing symptoms based on the affected area. For instance, a stroke may occur if emboli reach the brain, while a pulmonary embolism affects the lungs, and infarctions can occur in other organs.
  • Heart Failure: Symptoms of heart failure, such as severe fatigue, shortness of breath, and swelling in the legs or abdomen, can develop if endocarditis significantly affects the heart valves.

Diagnosis of Endocarditis

A thorough history-taking and physical examination are vital in diagnosing endocarditis. A detailed medical and social history can reveal potential exposure to risk factors, and a physical exam can identify signs of infection and complications.Β Β 

Diagnostic Criteria and Evaluation

  • Duke Criteria: The Duke criteria are essential for diagnosing infective endocarditis, combining clinical, microbiological, and echocardiographic findings to establish a diagnosis.
  • Blood Cultures: Obtaining multiple blood cultures is crucial to identifying the causative organisms. This process involves drawing blood samples at different times to increase the likelihood of detecting the pathogens.
  • Echocardiography: Transthoracic (TTE) and transesophageal echocardiography (TEE) are used to visualize vegetations in the heart and assess valve damage. TEE is more sensitive and often used when TTE results are inconclusive.
  • Laboratory Tests: Additional tests can support the diagnosis by indicating inflammation and infection, including a complete blood count (CBC), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR).

Treatment and Management of Endocarditis

Medical management consists of aggressive antibiotic or antifungal treatments. Surgical intervention is often provided in conjunction with medical therapy if significant damage to the heart tissue or valves occurs. Hospitalization is usually required for monitoring and intensive treatment. Patients need close supervision to manage the infection and help prevent complications.

Medical Management

  • Antibiotic Therapy: The cornerstone of endocarditis treatment is intravenous antibiotic therapy. The choice of antibiotics is based on the infective organism, and treatment typically lasts several weeks to help ensure the infection is managed effectively.
  • Antifungal Therapy: Antifungal medications are required for fungal endocarditis. These infections are more challenging to manage and may necessitate longer therapy courses.

Surgical Interventions

  • Valve Repair or Replacement: Surgical intervention may be required to repair or replace damaged valves, mainly if the infection has caused significant valve dysfunction or if there are vegetations at risk of embolization.
  • Removal of Infected Tissue: Removal of infected tissue may be required to help prevent the spread of the infection and stabilize the patient's condition.

Prognosis and Complications

The prognosis of endocarditis depends on various factors, including the causative organism, the patient's overall health, and the presence of complications. Early diagnosis and appropriate management can support better outcomes.

Complications of endocarditis can include recurrent infections, heart failure, and stroke. These complications can significantly impact a patient's long-term health and quality of life.

Managing Complications

Early detection and management of complications are crucial for improving outcomes. Regular follow-up and monitoring are necessary to catch and address issues promptly.Β  Ongoing care, including patient education, is vital to help prevent recurrence. Patients should be educated on recognizing warning signs and adhering to preventive measures.

Prevention and Patient Education

Essential prevention strategies include the following measures:

  • Prophylactic antibiotics may be recommended for high-risk patients undergoing certain medical or dental procedures to help prevent endocarditis.
  • Maintaining good oral hygiene can help prevent infections that could lead to endocarditis. Routine dental check-ups and proper oral care are crucial.
  • Education on the risks of IV drug use and strategies for harm reduction can help prevent endocarditis in this high-risk population.

Patient and Caregiver Education

Understanding Endocarditis and Treatment Adherence -Patients and caregivers should understand the condition and the importance of adhering to treatment plans to support successful outcomes.

Educating patients and caregivers on recognizing warning signs of recurrence or complications can lead to timely medical intervention and better management of endocarditis.

[signup]

Key Takeaways

  • Endocarditis is an infection of the heart's inner lining, typically involving the valves.
  • The infection usually starts when bacteria or fungi enter the bloodstream and attach to heart valves, forming vegetations of microorganisms, platelets, and cellular debris.
  • Bacterial infections, particularly those caused by Streptococcus and Staphylococcus species, are the most common causes. Risk factors include pre-existing heart conditions, medical procedures, IV drug use, and immunocompromised states.
  • Recognizing symptoms like fever, chills, heart murmurs, fatigue, shortness of breath, and complications such as embolic events and heart failure is essential.
  • The Duke criteria, blood cultures, echocardiography, and laboratory tests are critical for diagnosing endocarditis.
  • Management involves intravenous antibiotic or antifungal therapy and may require surgical interventions such as valve repair or replacement.
  • Early detection and management are vital for a better prognosis, with potential complications including recurrent infections, heart failure, and stroke.
  • Preventive strategies like antibiotic prophylaxis for high-risk patients, good oral hygiene, and avoiding IV drug use, along with patient education, are crucial for reducing the risk of endocarditis.
  • Future therapies for endocarditis may include the development of more targeted antibiotics and antifungal treatments, as well as advances in non-invasive imaging techniques for earlier and more accurate diagnosis. Ongoing research efforts are directed toward understanding the molecular mechanisms of endocarditis to improve prevention and create personalized treatment plans.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!
  1. American Heart Association. (2021, March 4). Infective Endocarditis. Www.heart.org. https://www.heart.org/en/health-topics/infective-endocarditis
  2. Ashley, E. A., & Niebauer, J. (2017). Infective endocarditis. Nih.gov; Remedica. https://www.ncbi.nlm.nih.gov/books/NBK2208/
  3. Atkinson, J. B., Robinowitz, M., McAllister, H. A., Forman, M. B., & Virmani, R. (1984). Cardiac infections in the immunocompromised host. Cardiology Clinics, 2(4), 671–686. https://pubmed.ncbi.nlm.nih.gov/6400010/
  4. Bertagna, B. (2024, February 13). The Link Between Oral Health and Overall Well-Being. Rupa Health. https://www.rupahealth.com/post/the-link-between-oral-health-and-overall-well-being
  5. Christie, J. (2024, May 17). How to Spot the Top Warning Signs of a Stroke. Rupa Health. https://www.rupahealth.com/post/how-to-spot-the-top-warning-signs-of-a-stroke
  6. Cleveland Clinic. (2019, April 29). Endocarditis. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16957-endocarditis
  7. Cleveland Clinic. (2022, April 11). Infective Endocarditis Surgery. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/17125-infective-endocarditis-surgery
  8. Cloyd, J. (2023a, April 20). Antibiotics 101: What You Need To Know. Rupa Health. https://www.rupahealth.com/post/antibiotics-101-what-you-need-to-know
  9. Cloyd, J. (2023b, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia
  10. Cloyd, J. (2023c, December 1). How to Interpret CBC Results: A Comprehensive Guide. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-cbc-results-a-comprehensive-guide
  11. Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue
  12. De Silva, K., Fife, A., Murgatroyd, F., & Gall, N. (2009). Pacemaker endocarditis: an important clinical entity. Case Reports, 2009(Nov 18), bcr0220091608–bcr0220091608. https://doi.org/10.1136/bcr.02.2009.1608
  13. Fowler, V. G., Durack, D. T., Selton-Suty, C., Athan, E., Bayer, A. S., Chamis, A. L., Dahl, A., DiBernardo, L., Durante-Mangoni, E., Duval, X., Fortes, C., FosbΓΈl, E., Hannan, M. M., Hasse, B., Hoen, B., Karchmer, A. W., Mestres, C. A., Petti, C. A., Pizzi, M. N., & Preston, S. D. (2023). The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 77(4), ciad271. https://doi.org/10.1093/cid/ciad271
  14. Hurrell, H., Roberts-Thomson, R., & Prendergast, B. D. (2020). Non-infective endocarditis. Heart, 106(13), 1023–1029. https://doi.org/10.1136/heartjnl-2019-315204
  15. Khakham, C. (2023, June 8). Exploring the Complexities of Autoimmune Diseases: Unraveling Mechanisms, Risk Factors, and Integrative Approaches to Testing, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/understanding-autoimmune-diseases-mechanisms-and-risk-factors
  16. Malani, S. (2023, February 22). Inflammatory Markers 101: How To Interpret. Rupa Health. https://www.rupahealth.com/post/inflammatory-markers-101-what-do-they-mean
  17. Mayo Clinic. (2020). Endocarditis - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/endocarditis/symptoms-causes/syc-20352576
  18. Ojha, N., & Dhamoon, A. S. (2020). Fungal Endocarditis. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532987/
  19. Penn Medicine. (2020, December 24). Endocarditis - Symptoms and Causes. Www.pennmedicine.org. https://www.pennmedicine.org/for-patients-and-visitors/patient-information/conditions-treated-a-to-z/endocarditis
  20. Pericàs, J. M., HernÑndez-Meneses, M., Muñoz, P., Álvarez-Uría, A., Pinilla-Llorente, B., de Alarcón, A., Reviejo, K., Fariñas, M. C., Falces, C., Goikoetxea-Agirre, J., GÑlvez-Acebal, J., Hidalgo-Tenorio, C., Gómez-Nebreda, E., & Miro, J. M. (2021). Outcomes and Risk Factors of Septic Shock in Patients With Infective Endocarditis: A Prospective Cohort Study. Open Forum Infectious Diseases, 8(6). https://doi.org/10.1093/ofid/ofab119
  21. Rupa Health. (n.d.-a). C-Reactive Protein. Rupa Health. https://www.rupahealth.com/biomarkers/c-reactive-protein
  22. Rupa Health. (n.d.). Erythrocyte Sedimentation Rate. Rupa Health. https://www.rupahealth.com/biomarkers/esr
  23. Sordelli, C., Fele, N., Mocerino, R., Weisz, S. H., Ascione, L., Caso, P., Carrozza, A., Tascini, C., De Vivo, S., & Severino, S. (2019). Infective Endocarditis: Echocardiographic Imaging and New Imaging Modalities. Journal of Cardiovascular Echography, 29(4), 149–155. https://doi.org/10.4103/jcecho.jcecho_53_19
  24. Sweetnich, J. (2023, June 15). What is the Diabetes Plate Method? Rupa Health. https://www.rupahealth.com/post/what-is-the-diabetes-plate-method
  25. Texas Heart Institute. (2018). Infective Endocarditis | Texas Heart Institute. Texas Heart Institute. https://www.texasheart.org/heart-health/heart-information-center/topics/infective-endocarditis/
  26. Tous-Romero, F., Delgado-MΓ‘rquez, A. M., Gargallo-Moneva, V., & Zarco-Olivo, C. (2017). Cutaneous vasculitis: a presentation with endocarditis to keep in mind. Anais Brasileiros de Dermatologia, 92(4), 594–595. https://doi.org/10.1590/abd1806-4841.20176317
  27. Vivian, C. (2019). Pathogenesis of vegetation formation in infective endocarditis. Uptodate.com. https://www.uptodate.com/contents/pathogenesis-of-vegetation-formation-in-infective-endocarditis
  28. Yallowitz, A. W., & Decker, L. C. (2023, April 24). Infectious Endocarditis. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557641/
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source